Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intervention for Teens With ADHD and Substance Use
NCT02502799Phase 3Terminated
- Sponsor
- Florida International University
- Start
- Jul 2015
- Primary completion
- Aug 2021
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (3 arms), sponsored by Florida International University. Primary endpoints: Number of Participants With Past 90-day Alcohol Use at 6 months and Number of Participants With Evidence of Illicit Substances in Urine Screen at 6 months. Started Jul 2015; status: terminated.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT02502799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02502799.